(PharmaNewsWire.Com, March 31, 2017 ) As per the syndicated report published by Market Data Forecast Europe Cancer Immunotherapy Market which is estimated to be USD 13.2 billion in 2016 is poised to reach USD 23.41 billion by 2021, at a CAGR of 12.45 % from 2016 to 2021. It can attributed to the factors such as Changing life style, increasing occurrence of cancer, Smoking and high efficacy of immunotherapy and excessive alcoholic intake, compared to other treatments, reduced chance of recurrence of cancer and less side effects associated with cancer immunotherapy .However certain challenges like limited information on cancer immunobiology and Cost of cancer therapies must be dealt with to attain the full potential.
To give a brief idea Healing of disease by improving and inducing immune response for the prevention of disease is termed as immunotherapy. It is an activation immunotherapy. Immune system is a compilation of organs and special cells that defend the body from infections and other diseases, and safeguard from cancer in number of ways. The immune system keeps path of all substances found in body. The immune response can destroy everything containing the foreign matter, such as microbes or cancer cells. Europe Cancer Immunotherapy Market is segmented based on type, application, administration and end users as mentioned below for attaining a more granular perspective of the market. In the report each sub-segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Application: Breast Lung Melanoma Colorectal Head & Neck Prostate others
Based on Product Type: Monoclonal Antibodies Checkpoint inhibitors/immune modulators Therapeutic cancer vaccines Oncolytic virus immunotherapy Cytokines Adoptive T cell transfer Adjuvant Immunotherapy Interferons Interleukins BCG Others
Based on Mode of Administration: Intravenous Oral Topical Intravesical
Based on End users: Hospitals Clinics
Europe is an amalgamation of major economies like Germany, Spain, Italy, U.K. and France among others to name a few. The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well (Rest of Europe). As per the study France is poised to hold the major market share while Germany is the fastest growing market in this region.
Some of the major companies dominating the global market are Amgen, Novartis Pharmaceuticals Corporation, GlaxoSmithKline Pharmaceuticals Limited, Medivation, Advaxis, Merck & Co. F. Hoffmann-La Roche Ltd, AstraZeneca plc, Viralytics, Bristol-Myers Squibb, and Celgene Corp, Pfizer, Immunomedics.
The Cancer Immunotherapy market study offers the following deliverables:
Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries
Meticulously identifying the key areas of market growth by providingmarket size forecasts and y-o-y estimations at a Segment-level analysis
Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors thataffect the European market presented in the form ofPESTLE and Porters Five Forces Analyses
Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
About Market Data Forecast: The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
